TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,866 Cr | ₹1,844 Cr | ₹1,944 Cr | ₹1,632 Cr | ₹1,523 Cr |
What is the latest Sundry Debtors ratio of TORRENT PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹1,866 Cr |
| Mar2024 | ₹1,844 Cr |
| Mar2023 | ₹1,944 Cr |
| Mar2022 | ₹1,632 Cr |
| Mar2021 | ₹1,523 Cr |
How is Sundry Debtors of TORRENT PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,866 Cr | 1.20 | |
| Mar2024 | ₹1,844 Cr | -5.12 | |
| Mar2023 | ₹1,944 Cr | 19.07 | |
| Mar2022 | ₹1,632 Cr | 7.16 | |
| Mar2021 | ₹1,523 Cr | - | |
Compare Sundry Debtors of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹129,026.8 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹90,491.0 Cr | 0.8% | -3% | -26.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.3% |
1.6% |
12.1% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses